指南与共识免疫规划卫生政策与健康促进

2019至2021年美国13至17岁青少年HPV疫苗提供者推荐的地域差异

Regional differences in provider recommendation of HPV vaccines among 13-to-17 year old adolescents from 2019 to 2021.
指南 / 共识 · Vaccine · 2024-05-24

本研究利用2019-2021年国家免疫调查-青少年数据(n=50,739名受访者),采用横断面设计分析医疗服务提供者推荐HPV疫苗的地域差异。结果显示,中西部(aOR 1.17,95%CI 1.06-1.29)和东北部(aOR 1.38,95%CI 1.23-1.56)的推荐 odds 高于南部;2020年推荐 odds 高于2019年(aOR 1.16,95%CI 1.03-1.30)。结论认为南部推荐仍落后于其他地区,需更多努力改善该地区HPV疫苗接种推荐。

要点

  • 中西部和东北部提供者推荐HPV疫苗的 odds 高于南部。
  • 2020年提供者推荐 odds 高于2019年。
  • 南部地区HPV疫苗推荐仍落后于其他地区。

核心结论

  • 2019至2020年推荐改善是重要公共卫生进展,但南部推荐仍落后于其他地区,需更多努力改善该地区HPV疫苗接种推荐。

研究设计与样本

  • 采用横断面设计分析2019-2021年国家免疫调查-青少年数据,样本为50,739名受访者,进行逻辑回归和调节分析。

主要发现

  • 中西部推荐 odds 高于南部(aOR 1.17,95%CI 1.06-1.29),东北部高于南部(aOR 1.38,95%CI 1.23-1.56)。
  • 2020年提供者推荐 odds 高于2019年(aOR 1.16,95%CI 1.03-1.30)。
  • 性别、年龄、种族/民族、健康保险状况和贫困状况与HPV疫苗接种推荐相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The prevalence of recommendation of human papillomavirus (HPV) vaccination by health care providers has improved over the last decade. However, research to determine whether the COVID-19 pandemic affected the progress in recommendation among adolescents across the U.S. regions has been limited. Therefore, the present study was conducted to determine if region was associated with provider recommendation of HPV vaccines in 2019-2021 and whether changes in recommendations varied by region. METHOD: Using a cross-sectional design to examine National Immunization Survey-Teen (2019-2021) data, logistic regression and moderation analyses were performed to model region variation in HPV vaccine recommendations (n = 50,739 respondents). RESULTS: The odds of recommendation were higher in the Midwest (aOR, 1.17 [95% CI, 1.06-1.29]), and Northeast (aOR, 1.38 [95% CI, 1.23-1.56]) regions than in the South region. Also, the odds of provider recommendation were higher in 2020 (aOR,1.16 [95% CI, 1.03-1.30]) than in 2019. Other variables-sex, age, race/ethnicity, health insurance status, and poverty status-were associated with recommendation of HPV vaccination. CONCLUSION: Although the improvement in recommendation from 2019 to 2020 is an important public health gain, recommendation in the South still lags behind that in other regions. More efforts are needed to improve HPV vaccination recommendations in this region.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Lynette Ejezie C, Cuccaro P, Savas LS, et al. Regional differences in provider recommendation of HPV vaccines among 13-to-17 year old adolescents from 2019 to 2021. Vaccine. 2024. PMID: 38796327. doi:10.1016/j.vaccine.2024.05.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。